Sebela Pharmaceuticals Inc. is committed to improving patients lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women's health diseases. To fulfill our commitment to improving patient's lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities.
Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.